• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

去甲基化处理可恢复 hic1 的表达并损害头颈部鳞状细胞癌的侵袭性。

Demethylation treatment restores hic1 expression and impairs aggressiveness of head and neck squamous cell carcinoma.

机构信息

Department of Otolaryngology, Head and Neck Surgery, University Medical Center of the Johannes Gutenberg University Mainz, Mainz, Germany.

出版信息

Oral Oncol. 2010 Sep;46(9):678-83. doi: 10.1016/j.oraloncology.2010.06.016. Epub 2010 Aug 21.

DOI:10.1016/j.oraloncology.2010.06.016
PMID:20729134
Abstract

Promoter hypermethylation of tumor suppressor genes is a common feature of primary cancer cells. However, at date the somatic epigenetic events that occur in head and neck squamous cell carcinoma (HNSCC) tumorigenesis are not yet been well defined. In the present study we analysed the methylation status of the gene hypermethylated in cancer-1 (hic1), a gene located on chromosome 17p13.3, a region frequently lost in HNSCC. We analysed 22 HNSCC samples and three cell lines using methylation specific PCR (MSP). We found hic1 methylated in 21 out of 22 samples and in all three cell lines. Treatment of the cell lines with the demethylating agent 5-Azacytidin (5-Aza) resulted in the demethylation of the hic1 promoter and reactivation of hic1 expression as determined by MSP, qPCR and Western blot. Functional analyses revealed decreased proliferative activity and colony forming ability of treated cells. In summary, we found in HNSCC hic1 regulated by promoter methylation. 5-Aza application resulted in the reexpression of hic1 and was followed by decreased aggressiveness of the cancer cells. Our data indicate that hic1 might be a player in HNSCC development and suggest further evaluation of 5-Aza for HNSCC treatment.

摘要

抑癌基因启动子的异常甲基化是原发性癌细胞的一个常见特征。然而,目前为止,发生在头颈部鳞状细胞癌(HNSCC)肿瘤发生中的体细胞表观遗传事件尚不完全清楚。在本研究中,我们分析了位于 17p13.3 染色体上的基因 hypermethylated in cancer-1(hic1)的甲基化状态,该基因位于 HNSCC 中经常丢失的区域。我们使用甲基化特异性 PCR(MSP)分析了 22 个 HNSCC 样本和 3 个细胞系。我们发现 hic1 在 22 个样本中的 21 个和所有 3 个细胞系中均发生甲基化。用去甲基化剂 5-氮杂胞苷(5-Aza)处理细胞系后,通过 MSP、qPCR 和 Western blot 确定 hic1 启动子去甲基化和 hic1 表达重新激活。功能分析显示,处理后的细胞增殖活性和集落形成能力降低。总之,我们在 HNSCC 中发现 hic1 受启动子甲基化调控。5-Aza 的应用导致 hic1 的重新表达,并随后导致癌细胞侵袭性降低。我们的数据表明 hic1 可能是 HNSCC 发展的参与者,并提示进一步评估 5-Aza 用于 HNSCC 治疗。

相似文献

1
Demethylation treatment restores hic1 expression and impairs aggressiveness of head and neck squamous cell carcinoma.去甲基化处理可恢复 hic1 的表达并损害头颈部鳞状细胞癌的侵袭性。
Oral Oncol. 2010 Sep;46(9):678-83. doi: 10.1016/j.oraloncology.2010.06.016. Epub 2010 Aug 21.
2
Promoter methylation of MGMT, MLH1 and RASSF1A tumor suppressor genes in head and neck squamous cell carcinoma: pharmacological genome demethylation reduces proliferation of head and neck squamous carcinoma cells.MGMT、MLH1 和 RASSF1A 肿瘤抑制基因启动子甲基化与头颈部鳞状细胞癌:药物基因组去甲基化可降低头颈部鳞状细胞癌细胞的增殖。
Oncol Rep. 2012 Apr;27(4):1135-41. doi: 10.3892/or.2012.1624. Epub 2012 Jan 9.
3
Pharmacological genome demethylation increases radiosensitivity of head and neck squamous carcinoma cells.药理基因组去甲基化增加头颈部鳞状细胞癌细胞的放射敏感性。
Int J Mol Med. 2012 Mar;29(3):505-9. doi: 10.3892/ijmm.2011.843. Epub 2011 Nov 21.
4
Tumor suppressor activity of CCAAT/enhancer binding protein alpha is epigenetically down-regulated in head and neck squamous cell carcinoma.CCAAT/增强子结合蛋白α的肿瘤抑制活性在头颈部鳞状细胞癌中发生表观遗传下调。
Cancer Res. 2007 May 15;67(10):4657-64. doi: 10.1158/0008-5472.CAN-06-4793.
5
Deleted in colorectal cancer is a putative conditional tumor-suppressor gene inactivated by promoter hypermethylation in head and neck squamous cell carcinoma.结直肠癌缺失基因是一种假定的条件性肿瘤抑制基因,在头颈部鳞状细胞癌中因启动子高甲基化而失活。
Cancer Res. 2006 Oct 1;66(19):9401-7. doi: 10.1158/0008-5472.CAN-06-1073.
6
Patterns of gene promoter methylation in squamous cell cancer of the head and neck.头颈部鳞状细胞癌中的基因启动子甲基化模式
Oncogene. 2002 Jun 20;21(27):4231-6. doi: 10.1038/sj.onc.1205528.
7
FOXE1 is a target for aberrant methylation in cutaneous squamous cell carcinoma.FOXE1 是皮肤鳞状细胞癌中异常甲基化的靶标。
Br J Dermatol. 2010 May;162(5):1093-7. doi: 10.1111/j.1365-2133.2009.09560.x. Epub 2009 Oct 21.
8
5-Aza-2'-deoxycytidine induces retinoic acid receptor-beta(2) demethylation and growth inhibition in esophageal squamous carcinoma cells.5-氮杂-2'-脱氧胞苷诱导食管鳞状癌细胞中视黄酸受体-β(2)去甲基化并抑制其生长。
Cancer Lett. 2005 Dec 18;230(2):271-83. doi: 10.1016/j.canlet.2005.01.012.
9
Hypermethylation of HIC1 promoter and aberrant expression of HIC1/SIRT1 might contribute to the carcinogenesis of pancreatic cancer.HIC1 启动子的高甲基化和 HIC1/SIRT1 的异常表达可能有助于胰腺癌的发生。
Ann Surg Oncol. 2013 Dec;20 Suppl 3:S301-11. doi: 10.1245/s10434-012-2364-9. Epub 2012 May 3.
10
Resetting the histone code at CDKN2A in HNSCC by inhibition of DNA methylation.通过抑制DNA甲基化重置头颈部鳞状细胞癌中CDKN2A的组蛋白密码。
Oncogene. 2003 Dec 4;22(55):8902-11. doi: 10.1038/sj.onc.1207050.

引用本文的文献

1
Epigenomic Dysregulation in Youth Vapers: Implications for Disease Risk Assessment.青少年电子烟使用者的表观基因组失调:对疾病风险评估的影响
Am J Respir Cell Mol Biol. 2025 Feb;72(2):206-218. doi: 10.1165/rcmb.2024-0207OC.
2
Ferroptosis-related gene HIC1 in the prediction of the prognosis and immunotherapeutic efficacy with immunological activity.铁死亡相关基因 HIC1 与免疫活性预测预后和免疫治疗疗效的关系。
Front Immunol. 2023 Jun 14;14:1182030. doi: 10.3389/fimmu.2023.1182030. eCollection 2023.
3
Hypermethylation of the HIC1 promoter and aberrant expression of HIC1/SIRT1 contribute to the development of thyroid papillary carcinoma.
HIC1启动子的高甲基化以及HIC1/SIRT1的异常表达促进甲状腺乳头状癌的发展。
Oncotarget. 2016 Dec 20;7(51):84416-84427. doi: 10.18632/oncotarget.12936.
4
Epigenetic silencing of HIC1 promotes epithelial-mesenchymal transition and drives progression in esophageal squamous cell carcinoma.HIC1的表观遗传沉默促进上皮-间质转化并推动食管鳞状细胞癌进展。
Oncotarget. 2015 Nov 10;6(35):38151-65. doi: 10.18632/oncotarget.5832.
5
Reactivation of HIC-1 gene by saRNA inhibits clonogenicity and invasiveness in breast cancer cells.saRNA介导的HIC-1基因激活抑制乳腺癌细胞的克隆形成能力和侵袭能力。
Oncol Lett. 2015 Jan;9(1):159-164. doi: 10.3892/ol.2014.2633. Epub 2014 Oct 24.
6
Deciphering HIC1 control pathways to reveal new avenues in cancer therapeutics.解析 HIC1 调控通路,揭示癌症治疗新途径。
Expert Opin Ther Targets. 2013 Jul;17(7):811-27. doi: 10.1517/14728222.2013.788152. Epub 2013 Apr 9.
7
MAGEB2 is activated by promoter demethylation in head and neck squamous cell carcinoma.MAGEB2 在前头颈鳞状细胞癌中被启动子去甲基化激活。
PLoS One. 2012;7(9):e45534. doi: 10.1371/journal.pone.0045534. Epub 2012 Sep 24.
8
Lessons learned from next-generation sequencing in head and neck cancer.从头颈癌的下一代测序中吸取的经验教训。
Head Neck. 2013 Mar;35(3):454-63. doi: 10.1002/hed.23100. Epub 2012 Aug 21.
9
Role of DNA methylation in head and neck cancer.DNA 甲基化在头颈部癌症中的作用。
Clin Epigenetics. 2011 Aug;2(2):123-50. doi: 10.1007/s13148-011-0045-3. Epub 2011 Jul 9.
10
Promoter methylation of MGMT, MLH1 and RASSF1A tumor suppressor genes in head and neck squamous cell carcinoma: pharmacological genome demethylation reduces proliferation of head and neck squamous carcinoma cells.MGMT、MLH1 和 RASSF1A 肿瘤抑制基因启动子甲基化与头颈部鳞状细胞癌:药物基因组去甲基化可降低头颈部鳞状细胞癌细胞的增殖。
Oncol Rep. 2012 Apr;27(4):1135-41. doi: 10.3892/or.2012.1624. Epub 2012 Jan 9.